The liver is the sixth most common site of primary cancer in humans, and generally arises in
a background of cirrhosis and inflammation. Moreover, the liver is frequently colonized by …

Complex interactions between the immune system and tumor cells exist throughout the
initiation and development of cancer. Although the immune system eliminates malignantly …

Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors,
and many patients are diagnosed with advanced disease. The treatment of advanced liver …

Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer-related death.
The immune-rich contexture of the HCC microenvironment makes this tumour an appealing …

Liver disease is a major health problem that endangers human health worldwide. Currently,
whole organ allograft transplantation is the gold standard for the treatment of end-stage liver …

New advances in the design and manufacture of monoclonal antibodies, bispecific T cell
engagers, and antibody-drug conjugates make the antibody-directed agents more powerful …

Hepatocellular carcinoma (HCC) is highly malignant and prone to metastasize due to the
heterogeneous and immunosuppressive tumor microenvironment (TME). Programmed cell …

Cases of hepatocellular carcinoma (HCC) are rapidly rising. This is particularly the case in
the Western world, as a result of increasing rates of chronic liver disease, secondary to …

Ultrasound is one of the safest and most advanced medical imaging technologies that is
widely used in clinical practice. Ultrasound microbubbles, traditionally used for contrast …

Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the
world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have …